Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Ocugen, Inc. OCGN
$0.67
-$0.03 (-4.61%)
На 18:02, 12 мая 2023
+646.27%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
164114295.00000000
-
week52high
3.11
-
week52low
0.67
-
Revenue
0
-
P/E TTM
-2
-
Beta
3.70514000
-
EPS
-0.37000000
-
Last Dividend
0.00000000
-
Next Earnings Date
05 мая 2023 г. в 12:30
Описание компании
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Mizuho | Buy | 23 авг 2022 г. | |
HC Wainwright & Co. | Buy | Buy | 15 авг 2022 г. |
Cantor Fitzgerald | Overweight | 02 июн 2022 г. | |
HC Wainwright & Co. | Buy | Buy | 12 мая 2022 г. |
HC Wainwright & Co. | Buy | Buy | 28 февр 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Musunuri Shankar | D | 326543 | 100000 | 17 янв 2023 г. |
Musunuri Shankar | D | 2227950 | 100000 | 17 янв 2023 г. |
Musunuri Shankar | A | 2327950 | 100000 | 17 янв 2023 г. |
Upadhyay Arun | A | 379357 | 379357 | 03 янв 2023 г. |
Upadhyay Arun | A | 400083 | 315924 | 03 янв 2023 г. |
Musunuri Shankar | A | 1771654 | 1771654 | 03 янв 2023 г. |
Musunuri Shankar | A | 2227950 | 1475410 | 03 янв 2023 г. |
Crespo Jessica | A | 147638 | 147638 | 03 янв 2023 г. |
Crespo Jessica | A | 163391 | 122951 | 03 янв 2023 г. |
Musunuri Shankar | D | 426543 | 95809 | 16 дек 2022 г. |
Новостная лента
7 Heavily Shorted Penny Stocks for Your Short-Squeeze Watch List
InvestorPlace
03 февр 2023 г. в 11:18
For medium to long-term investors, it's essential to screen fundamentally strong businesses when looking to add exposure to a given sector or type of stock. However, from a trading perspective, an under-performing stock can be a good investment within a limited time horizon.
3 Sorry Pharma Stocks to Sell in February Before It's Too Late
InvestorPlace
01 февр 2023 г. в 13:55
Pharmaceutical stocks have been relatively subdued in the last 12 months. During this period, the S&P 500 Pharmaceutical Industry index has trended higher by 3.5%.
3 of the Fastest-Growing Stocks on the Planet in 2023
The Motley Fool
26 янв 2023 г. в 05:21
These hypergrowth stocks are expected to deliver up to 1,075% sales growth this year.
3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street
The Motley Fool
23 янв 2023 г. в 05:21
Select analysts expect these small-caps stocks to catapult higher in the new year.
7 ‘Loser' Stocks to Short for Big Profits
InvestorPlace
11 янв 2023 г. в 07:03
In 2022, I was able to greatly reduce my stock portfolio's losses by shorting several U.S. equities. I found it fairly easy to find favorable stocks to short, as the valuations of many companies were ridiculously high last year, and many stocks were pricing in scenarios that almost certainly would never materialize.